Comparison
2q33 1 Microdeletion Syndrome C4706258 vs 17q12 Recurrent Deletion Syndrome C6011081
Clinical comparison between 2q33 1 Microdeletion Syndrome and 17q12 Recurrent Deletion Syndrome for differential diagnosis and treatment planning.
2q33 1 Microdeletion Syndrome C4706258
A rare chromosomal deletion involving part of chromosome 2. It may cause developmental delay, growth issues, feeding difficulties, and skeletal abnormalities. Care involves developmental support and specialist monitoring.
17q12 Recurrent Deletion Syndrome C6011081
A genetic condition from deletion on chromosome 17. Can involve developmental delays, neurological features, and potential kidney involvement. Management requires regular monitoring and supportive therapies.
6 comparison axes
Onset
2q33 1 Microdeletion Syndrome C4706258
0-null
17q12 Recurrent Deletion Syndrome C6011081
0-null
Onset patterns differ
Severity
2q33 1 Microdeletion Syndrome C4706258
severe
17q12 Recurrent Deletion Syndrome C6011081
moderate
Different severity levels
Chronic
2q33 1 Microdeletion Syndrome C4706258
Chronic
17q12 Recurrent Deletion Syndrome C6011081
Chronic
Differing course
Communicable
2q33 1 Microdeletion Syndrome C4706258
No
17q12 Recurrent Deletion Syndrome C6011081
No
Different transmission
Body System
2q33 1 Microdeletion Syndrome C4706258
congenital
17q12 Recurrent Deletion Syndrome C6011081
congenital
Same/different system
Category
2q33 1 Microdeletion Syndrome C4706258
rare-disease
17q12 Recurrent Deletion Syndrome C6011081
genetic
Different category
Bottom line
2q33-1-microdeletion-syndrome-C4706258 and 17q12-recurrent-deletion-syndrome-C6011081 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q33 1 Microdeletion Syndrome C4706258 | 17q12 Recurrent Deletion Syndrome C6011081 | Discriminating power |
|---|---|---|---|
| Developmental delay | May occur with growth, feeding, or skeletal concerns. | May occur with neurological features or possible kidney involvement. | Low |
| Associated organ features | Growth issues, feeding difficulties, and skeletal abnormalities are described. | Neurological features and potential kidney involvement are described. | Moderate |
| Reported severity | Source classification is severe, but individual course is not established. | Source classification is moderate, but individual course is not established. | Moderate |
When to favor each condition
Choose 2q33 1 Microdeletion Syndrome C4706258 when
Chromosome 2 deletion is confirmed
The supplied description specifically involves part of chromosome 2.
High
Feeding, growth, or skeletal concerns predominate
These features are mentioned for the left condition, not the right.
Moderate
Broad developmental support is needed
Care is described as developmental support with specialist monitoring.
Moderate
Choose 17q12 Recurrent Deletion Syndrome C6011081 when
Chromosome 17 deletion is confirmed
The supplied description specifically involves chromosome 17.
High
Kidney involvement is a concern
Potential kidney involvement is mentioned only for the right condition.
Moderate
Neurological features accompany delay
Neurological features are described for the right condition.
Moderate
How key tests differ
| Test | 2q33 1 Microdeletion Syndrome C4706258 | 17q12 Recurrent Deletion Syndrome C6011081 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or genetic testing | May identify a deletion involving chromosome 2. | May identify a recurrent deletion involving chromosome 17. | A test result supports, but does not by itself establish, the clinical diagnosis. |
| Growth and feeding assessment | May show growth or feeding difficulties. | No specific growth or feeding pattern is supplied. | Abnormal findings need clinical correlation and do not distinguish the syndromes alone. |
| Kidney evaluation | No kidney-specific expectation is supplied. | Evaluation may be considered because kidney involvement is possible. | An abnormal kidney finding is not itself a diagnosis and requires clinician review. |
Prognosis comparison
2q33 1 Microdeletion Syndrome C4706258
- Outcome
- Long-term outcome is not established; source severity is severe.
- Factors
- Developmental delay, growth, feeding, and skeletal issues may influence care needs.
17q12 Recurrent Deletion Syndrome C6011081
- Outcome
- Long-term outcome is not established; source severity is moderate.
- Factors
- Developmental, neurological, and possible kidney features may influence monitoring.
Time frame: Both are described as chronic, but exact course is not supplied.
Chromosome involved, confirmed features, and clinician assessment matter; mortality and exact prognosis are not established.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental challenges | Developmental delay may occur and can be substantial. Developmental delays and neurological features may occur. Severity and long-term impact are not established from the supplied data. |
| Nutrition and growth | Growth issues and feeding difficulties are described. No specific nutrition complication is supplied. Monitoring needs should be individualized by clinicians. |
| Organ-system concerns | Skeletal abnormalities may occur. Potential kidney involvement is described. Neither finding is definitive, and specialist assessment is appropriate. |
Patient education highlights
- HighGenetic confirmation
Ask which chromosome is involved and how the result relates to symptoms.
- HighMonitoring
Both conditions may need developmental support, specialist review, and regular monitoring.
- MediumVariable features
Not every person has every described feature; an abnormal test is not automatically a diagnosis.